Home » Newsletters » BioWorld Science

BioWorld Science

May 18, 1998

View Archived Issues

Company Profile: AdProTech

Phytera and Galileo enter into collaborative agreement

Rhone-Poulenc Rorer expands licensing agreement with Enzon for Oncaspar

CombiChem achieves milestone in Roche Bioscience collaboration

Maxim's mucosal vaccine research published

The Liposome Company: Q1 1998 highlights

Oxygent research agreement restructured

SciClone and Schering-Plough begin phase III trial of Zadaxin in Japan

Neurocrine Biosciences: Q1 1998 highlights

Merck characterizes new orally bioavailable thrombin inhibitor: L-374087

Ondansetron suppresses spontaneous sleep apnea in rats

Muse approved in Sweden

Barr receives FDA approval for generic form of ReVia

Rhone-Poulenc Rorer submits NDA for ebastine in U.S.

Oncogene Science Diagnostics and Fujirebio form cancer diagnostics collaboration

Another market introduction for Xalatan

SU-5416 advances to phase I/II trials in Kaposi's sarcoma

MRI with alpha(v)/beta(3)-targeted MAb as a method of detecting tumor angiogenesis

Recombinant antithrombin III pivotal clinical trials begin

AtheroGenics receives FDA approval to begin AGI-1067 trial

Unimed discontinues U.S. registration process for nitazoxanide indication

FDA advisory committee recommends approval of Thyrogen

European Commission approves Novartis' Exelon

U.S. patent issues for ImClone Systems' flk-1/KDR receptor-targeting antibodies

Scios and Janssen to copromote Risperdal

Palatin finalizes license for erectile dysfunction product

Mechanism of antitumor activity of clotrimazole identified

Zonagen, Schering AG to drop contraceptive vaccine collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...